GeneDx Advances Clinical Adoption Of Genomic Medicine With 27 Abstracts At American Society Of Human Genetics 2026

GeneDx presented 27 abstracts at the American Society of Human Genetics 2026, highlighting the clinical adoption of genomic medicine. The research emphasizes the role of exome and genome sequencing as a standard of care in areas such as rare diseases, autism, and newborn screening. This advancement supports the company's position in the genomic medicine market.